Quidel Market Cap 2006-2020 | QDEL

Quidel market cap history and chart from 2006 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Quidel market cap as of September 23, 2020 is $8.35B.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $8.347B $0.535B
Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women's health throughout the phases of their lives including reproductive status, pregnancy management and osteoporosis. Quidel also provides point-of-care diagnostics for infectious diseases, including influenza A and B, strep throat, H. pylori infection, chlamydia and infectious mononucleosis.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $185.552B 34.82
Medtronic (MDT) Ireland $140.269B 26.42
Stryker (SYK) United States $76.229B 29.56
Boston Scientific (BSX) United States $55.224B 31.90
Lonza Group Ag (LZAGY) Switzerland $46.431B 0.00
Baxter (BAX) United States $40.018B 24.47
Terumo (TRUMY) Japan $30.631B 39.15
Zimmer Biomet Holdings (ZBH) United States $28.066B 23.29
EssilorLuxottica Societe Anonyme (ESLOY) France $27.465B 0.00
ResMed (RMD) United States $24.961B 36.19
Sunny Optical Technology (SNPTF) China $17.659B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.515B 0.00
Bio-Rad Laboratories (BIO) United States $15.305B 69.22
Insulet (PODD) United States $15.136B 640.44
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
DiaSorin S.p.A (DSRLF) Italy $10.350B 0.00
GN STORE NORD (GNNDY) Denmark $10.221B 52.10
William Demant Holdings (WILYY) Denmark $7.100B 0.00
Perrigo (PRGO) Ireland $6.353B 10.90
Canopy Growth (CGC) Canada $5.964B 0.00
Hill-Rom Holdings (HRC) United States $5.488B 13.62
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.462B 0.00
Haemonetics (HAE) United States $4.284B 28.55
Neogen (NEOG) United States $4.165B 68.30
ICU Medical (ICUI) United States $3.965B 30.25
Envista Holdings (NVST) United States $3.774B 25.74
TG Therapeutics (TGTX) United States $3.247B 0.00
National Vision Holdings (EYE) United States $3.145B 488.88
GW Pharmaceuticals (GWPH) United Kingdom $3.136B 0.00
Abcam (ABCZY) $2.987B 0.00
NuVasive (NUVA) United States $2.615B 36.45
Agios Pharmaceuticals (AGIO) United States $2.529B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.824B 166.38
AtriCure (ATRC) United States $1.754B 0.00
NanoString Technologies (NSTG) United States $1.739B 0.00
Cardiovascular Systems (CSII) United States $1.396B 0.00
MacroGenics (MGNX) United States $1.396B 0.00
Aphria (APHA) Canada $1.308B 0.00
InMode (INMD) Israel $1.128B 28.44
Cerus (CERS) United States $1.037B 0.00
Quanterix (QTRX) United States $0.946B 0.00
Owens & Minor (OMI) United States $0.912B 20.43
BioLife Solutions (BLFS) United States $0.863B 449.67
OraSure Technologies (OSUR) United States $0.853B 0.00
Aurora Cannabis (ACB) Canada $0.845B 0.00
Lantheus Holdings (LNTH) United States $0.831B 11.52
PetIQ (PETQ) United States $0.830B 23.80
Meridian Bioscience (VIVO) United States $0.737B 17.01
Phibro Animal Health (PAHC) United States $0.710B 16.24
Vapotherm (VAPO) United States $0.680B 0.00
LeMaitre Vascular (LMAT) United States $0.657B 40.12
Omeros (OMER) United States $0.599B 0.00
Zynex (ZYXI) United States $0.596B 52.06
Eagle Pharmaceuticals (EGRX) United States $0.542B 76.54
Surmodics (SRDX) United States $0.523B 57.40
VAREX IMAGING (VREX) United States $0.470B 20.37
Cytosorbents (CTSO) United States $0.353B 0.00
HEXO (HEXO) $0.345B 0.00
Viemed Healthcare (VMD) United States $0.342B 12.24
Utah Medical Products (UTMD) United States $0.286B 24.53
Neptune Wellness Solutions (NEPT) Canada $0.267B 0.00
InfuSystems Holdings (INFU) United States $0.262B 49.88
Surface Oncology (SURF) United States $0.257B 0.00
Organigram Holdings (OGI) Canada $0.231B 0.00
Female Health (VERU) United States $0.189B 0.00
Chimerix (CMRX) United States $0.177B 0.00
Wound Management Technologies (SMTI) United States $0.163B 0.00
Fonar (FONR) United States $0.154B 13.68
Bovie Medical (APYX) United States $0.153B 0.00
Exagen (XGN) United States $0.140B 0.00
Liberty Health Sciences (LHSIF) United States $0.134B 0.00
Evolus (EOLS) United States $0.128B 0.00
Rockwell Medical (RMTI) United States $0.118B 0.00
Capricor Therapeutics (CAPR) United States $0.105B 0.00
Chembio Diagnostics (CEMI) United States $0.094B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.094B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.071B 0.00
United-Guardian (UG) United States $0.069B 15.46
Brainsway (BWAY) Israel $0.063B 0.00
MTech Acquisition (KERN) United States $0.057B 0.00
Nephros (NEPH) United States $0.054B 0.00
Trinity Biotech (TRIB) Ireland $0.052B 9.82
ImmuCell (ICCC) United States $0.038B 0.00
FSD PHARMA INC (HUGE) Canada $0.035B 0.00
Akers Biosciences Inc (AKER) United States $0.021B 0.00
GUARDION HEALTH (GHSI) United States $0.020B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.019B 0.00
NF Energy Saving (BIMI) China $0.018B 0.00
Myomo (MYO) United States $0.017B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00